Virtue Capital Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Virtue Capital Management’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,651	Closed	-$513K	–	353
2025 Q3	$513K	Buy	+3,651	New	+$513K	0.08%	173

Virtue Capital Management's OMIC Position: Q4 2025 in Review

Virtue Capital Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2025, closing a stake of 3,651 shares — an estimated $513K sold.

Virtue Capital Management first reported a position in OMIC in Q3 2025 and held it in 1 quarter. The position peaked at $513K in Q3 2025. 0 funds tracked by Wall St. Rank hold OMIC as of Q4 2025.

Virtue Capital Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
Virtue Capital Management sold 3,651 Singular Genomics Systems, Inc. Common Stock shares in Q4 2025, an estimated $513K.
Virtue Capital Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2025 and held it in 1 quarter.
Virtue Capital Management's Singular Genomics Systems, Inc. Common Stock position peaked at $513K in Q3 2025.
0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2025.

Based on Virtue Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.